AGP Picks
View all

Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on April 1, 2026

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
RemoniHealth Expands Hardware-Free "Vision-as-a-Service" Platform to Cover Over 90% of Chronic Eye Diseases
Stryker to announce financial results for its first quarter of fiscal year 2026
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD
Alignment Healthcare to Present at the BofA Securities Health Care Conference 2026
New global report reveals men and young adults driving soaring usage of wellness technologies
Picard Medical / SynCardia to Participate in Voice of the Patient Event During AZ Tech Week
Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)
Cost concerns now rival fear of cancer diagnosis, new survey finds
Axe Compute Reports $12 Million in Executed Agreements Providing $835 Thousand in Estimated Monthly Income Entering Q2 2026
Trevi Therapeutics to Participate in Upcoming Events
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
Avicanna Reports Full Year 2025 Audited Financial Statements
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing

Share this page:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.